Navigation Links
Harvard University: Big Pharma is Corrupted; CBCD Sees Connection between Corruption & Productivity Crisis in R&D
Date:11/1/2013

Rochester, NY (PRWEB) November 01, 2013

Big Pharma suffers from institutional corruption according to Harvard University researchers (1). They came to this conclusion after examining Pharma’s practices and policies in 5 different categories: systemic problems, medical research, medical knowledge and practice, marketing, and patient advocacy organizations. The CBCD believes this institutional corruption is a result of the productivity crisis in pharmaceutical R&D.

What is institutional corruption?

According to Marc A. Rodwin, one of the lead researchers, institutional corruption is “widespread or systemic practices, usually legal, that undermine an institution's objectives or integrity. Institutional corruption displaces some goals and compromises the attainment of others (2).”

An example of systemic corruption, (corruption of the entire system, or way of doing things) is Big Pharma’s funding of political campaigns, selectively providing information to legislators, subsidizing their work, and targeting campaign contributions to influential legislators and allies (1). Another example of a systemic problem is the fact that “Firms have strong financial incentives to develop so-called me-too drugs - products which are minor variations of existing drugs - and to heavily market them in ways that exaggerate their benefits and fail to reveal their full risks (1).”

The Harvard researchers found that Big Pharma manipulates physicians across America to achieve their financial goals. They wrote that “widespread practices in the medical and pharmaceutical industries can lead to doctors who are psychologically, financially, or intellectually dependent on drug companies (1).” In other words, Pharma turned these doctors into their agents. This is a phenomenon which has “resulted in…Doctors who take such misleading information at face value (and) prescribe drugs that are often unnecessary, harmful to patients, or more costly than equivalent medications (1).”

In short, the Harvard researchers “uncovered how pharmaceutical marketing …distorts medical practice… (1).”

When normal people become corrupted, it is usually due to extreme pressure. For example, when someone holds a gun to the head of one’s child, or when one is bankrupt and must still purchase food for one’s family…then one may be driven to extreme acts. The same holds true for Big Pharma. The productivity crisis is driving Pharma to extreme measures. These extreme measures were labeled by researchers as ‘institutional corruption.’

For more information on the productivity crisis in pharmaceutical R&D, please visit:

http://www.prweb.com/releases/2013/10/prweb11232090.htm

and

http://www.prweb.com/releases/2013/10/prweb11273236.htm

The CBCD invites pharmaceutical executives to contact the Center to discuss forward thinking strategies that can help reduce corruption while maximizing profits.

We invite the media to contact us for interviews at: info (at)buy-gene-eden(dot)com or phone 585-250-9999.

###

References:
(1)    http://www.law.harvard.edu/news/2013/10/25_edmond-j-safra-center-for-ethics-fellows-jlme.html
(2)    http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2298140
(3)    http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11290033.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Harvard researchers, pharma experts offer recommendations to expand access to clinical trial data
2. Genia Technologies, Columbia University, and Harvard University Awarded $5.25 Million Grant from NIH to Accelerate the Development of NanoTag DNA Sequencing Technology
3. Jeffrey Epstein, Science Financier, Changes the Course of Evolution at Harvard
4. Director of Proteomics at the Broad Institute of MIT and Harvard, Steven Carr, to Deliver Pittcon 2014 Wallace H. Coulter Plenary Lecture
5. Life Technologies Signs License and Collaborative Stem Cell Research Agreement with Harvard University
6. Harvard Wyss Institutes Lung-on-a-Chip wins prize for potentially reducing need for animal testing
7. Harvards Wyss Institute team creates versatile 3d nanostructures using DNA bricks
8. Harvards Wyss Institute models a human disease in an organ-on-a-chip
9. UMass Amherst, Harvard experts say better systems needed for medical device cybersecurity
10. Harvards Wyss Institute creates living human gut-on-a-chip
11. Harvards Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... of 13 prestigious awards honoring scientists who have made outstanding ... a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving ... marijuana products targeting the needs of consumers who are incorporating medical marijuana into ... in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving ...
(Date:10/7/2017)... Oct. 6, 2017  The 2017 Nobel Prize ... scientists, Jacques Dubochet, Joachim Frank and ... cryo-electron microscopy (cryo-EM) have helped to ... structural biology community. The winners worked with systems ... routinely produce highly resolved, three-dimensional images of protein ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
Breaking Biology News(10 mins):